Shree Ganesh Remedies Ltd develops a type of Cyclo-Propyl derivative

Shree Ganesh Remedies Ltd has successfully developed a certain type of Cyclo-Propyl derivative, which is currently being imported by most of manufacturers in India for synthesis of the drugs like Naltrexone and Buprenorphine.

The said Cyclo-Propyl derivative is developed in the laboratory of the Company situated at Ankleshwar, Gujarat on May 31, 2021.

The said product will cater both Domestic and International Market and it's commercial production is expected to start by first week of June, 2021. As it a basic building block we expect that it will find usage over a wide range of applications and will attract huge volumes in upcoming years.

Shares of Shree Ganesh Remedies Ltd was last trading in BSE at Rs.340 as compared to the previous close of Rs. 337.55. The total number of shares traded during the day was 11450 in over 516 trades.

The stock hit an intraday high of Rs. 366 and intraday low of 335. The net turnover during the day was Rs. 3915219.

Source : Equity Bulls

Keywords